Edouard Devaud
5 Papers
6 Citations
Edouard Devaud is an academic researcher. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
Suzana Margareth Lobo,Gaétan Plantefève,Girish Nair,Adilson Joaquim Cavalcante,Nara Franzin de Moraes,Estevao Nunes,Otis Barnum,Claudio Marcel Berdun Stadnik,Maria Patelli Lima,Muriel Lins,L. A. Hajjar,Christopher Lipinski,Shaheen Islam,Fabiano Ramos,Tiago Simon,Jean-Benoit Martinot,Thomas Guimard,Arnaud Desclaux,Bertrand Lioger,Fernando Carvalho Neuenschwander,Bruno DeSouza Paolino,Alpesh Amin,Samuel Amil Acosta,Daniel Forde Dilling,Edgardo Cartagena,Brian Snyder,Edouard Devaud,Ana Karolina Barreto Berselli Marinho,Suzana Tanni,Patricia Medeiros Milhomem Beato,Stephan De Wit,Vani Selvan,Jeffrey Gray,Ricardo Fernandez,Valérie Pourcher,Lee Maddox,Richard Kay,A. Azbekyan,Mounia Chabane,Cendrine Tourette,Luis Everton Esmeraldino,Pierre J. Dilda,René Lafont,Jean Mariani,Serge Camelo,Sandrine Rabut,Samuel Agus,Stanislas Veillet,Waly Dioh,Rob van Maanen,Capucine Morélot-Panzini +50 more
TL;DR: A phase 2/3 trial of oral 20-hydroxyecdysone (BIO101) in severe COVID-19 patients showed a 11.4% lower risk of respiratory failure or death by day 28, with a non-significant 44.6% mortality reduction over 90 days.
12
A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
Vincent Dubée,Pierre-Marie Roy,Bruno Vielle,Elsa Parot-Schinkel,Odile Blanchet,Astrid Darsonval,Caroline Lefeuvre,Chadi Abbara,Sophie Boucher,Edouard Devaud,Olivier Robineau,Patrick Rispal,Thomas Guimard,Emma d’Anglejean,Sylvain Diamantis,Marc-Antoine Custaud,Isabelle Pellier,Alain Mercat +17 more
TL;DR: In this trial involving mainly older patients with mild-to-moderate COVID-19, patients treated with hydroxychloroquine did not experience better clinical or virological outcomes than those receiving the placebo.
7
Long-term neuro-functional disability in adult patients with community-acquired bacterial meningitis
Souâd Akroum,Nathalie Dournon,Emmanuelle Varon,Bruno Mourvillier,Eric Oziol,Charles Burdet,Xavier Duval,Bruno Hoen,Sarah Tubiana,M.C. Ploy,François Caron,PE Bollaert,Olivier Gaillot,Mk Taha,Claire Poyart,Stéphane Bonacorsi,Frangois Vandenesch,Emmanuelle Cambau,Marc Lecuit,Alain Gravet,Bruno Frachet,Thomas De Broucker,D. Levy Bruhl,François Raffi,B. Abraham,Florence Ader,Emma Ancel,Nadia Anguel,Laurent Argaud,Sophie Arista,Laurence Armand-Lefevre,Marie-Nadege Bachelier,Stéphanie Balavoine,R. Baraduc,Guilène Barnaud,Guillaume Béraud,D. Bertei,Emile Bessède,T. Billard-Pomares,Charlotte Biron,G. Blanchard-Marche,S. Bland,Julien Boileau,Caroline Bornstain,Sandra Bourdon,Ann Rohrbach Bousquet,S. Boyer,Alexis Bozorg-Grayeli,L. Bret,François Bricaire,E. Brocas,Michel Brun,Jennifer Buret,Christophe Burucoa,Guillaume Camuset,Christophe Canevet,Anne Carricajo,I. Casin,D. Cassignard,B. Castan,Charles Cazanave,Thibaut Challan-Belval,C. Chandesris,V. Chanteperdrix-Marillier,Chantal Chaplain,Caroline Charlier-Woerther,Hélène Chaussade,Catherine Chirouze,Monique Chomarat,Yann-Eric Claessens,Betsy Clair,Danièle Combaux,Jean-Marie Conil,H Cordel,P. Cormier,Joel Cousson,Pierrick Cronier,Eric Cua,Vincent Daneluzzi,A. Dao Dubremetz,A. Defarcy,Nicolas Degand,Sophie Dekeyser,Déborah Delaune,Enrique D. Denes,D. Descamps,J. Desmaretz,Edouard Devaud,M. Di Palma,Sylvain Diamantis,Jean-Luc Diehl,Jérôme Dimet,Alexy Tran Dinh,Elodie Descloux,Julien Colot,Aurélie Emirian,Olivier Epaulard,Lélia Escaut,C. Fabe,Ted S. Ferry,H. Fiette,Clara Flateau,Nathalie Fonsale,Emmanuel Forestier,Nicolas Fortineau,T. Fraisse,Frederic Faibis,Marie Froidure,S. Gabriel-Solean,Amandine Gagneux-Brunon,Garandeau,M. García,V. Garnier,Shannon Gaudry,Raouf Ghozzi,V. Gregoire-Faucher,M. Grosset,Isabelle Gueit,Dominique Guelon,C. Guillet-Caruba,Thomas Guimard,Yves Guimard,Jérôme Guinard,T. Hadou,J. Helene,Sandrine Henard,Benoît Henry,Romain Hernu,A. Hochart,Nadia Idri,Gabrielle Illes,Xavier Jacob,Sylvain Jaffuel,Dirk Jan,Irène Jarrin,Françoise Jauréguy,Cédric Joseph,M.-E. Juvin,Sara Kayal,Mathieu Lafaurie,B. Lalanne,Isabelle Lamaury,Philippe Lanotte,Marie-Frédérique Lartigue,Yolanda Ortega Latorre,Patrice Laudat,E Laurens,Henri Laurichesse,Cécile Le Brun,Vincent Le Moing,Paul Le Turnier,Hervé Lécuyer,S Ledru,Laurence Legout,C. Legrix,Adrien Lemaignen,C. Lemble,Linda Lemee,Sophie Leotard,Olivier Lesens,Philippe Lesprit,Marion Levast,F. Louis,L. Quaesaet,N. Luizy,S. Males,Edith Malpote,Guillaume Martin-Blondel,Vito Bruno Martinez,René Masson,Olivier Matray,Aurore Mbadi,Frédéric Méchaï,Audrey Mérens,M C Meyohas,Gregg L. Michel,Arthur Michon,J. Mootien Yoganaden,David Morquin,Stéphane Mouly,Natacha Mrozek,S. Nguyen,Y Nguyen,A. Odinotte,Maja Ogielska,B. Page,E. Parisi Duchene,T Pasdeloup,Solène Patrat-Delon,Isabelle Patry,André Pechinot,Isabelle Pelloux,S. Picot,Joel Pierre,Lionel Piroth,Claire Plassart,P. Plessis,Christine Ploton,Marie-Cécile Ploy,L Portel,Mark Alan Poupard,Thierry Prazuck,A. Ramanantsoa,C. Rapp,Laurent Raskine,J. Raymond,Matthieu Revest,A. Riche,S. Robaday-Voisin,F Robin,F. Roblot,J. P. Romaszko,Franck Rousseau,Anne-Laure Roux,C. Royer,M. Saada,D Salmon,Carlo Saroufim,J. Schmit,Manuela Sebire,Christine Segonds,Farid Sifaoui,Valérie Sivadon-Tardy,Nathalie Soismier,Kenneth A. Solen,A. Sommabere,Olivia Son,J. Stahl,R. Steux,Simon Sunder,Florence Suy,Dibussi Tande,Jacques Tankovic,Sylvestre Tigaud,B Tourrand,Nadia Valin,Nicolas Van Grunderbeeck,Rémi Vatan,C. Venot,Michel Vergnaud,Vernet,Magali Vidal,V. Vitrat,Daniel Vittecoq,Fanny Vuotto,Amélie Chabrol,J. Cabalion,Cédric Laouénan,F. Mentré,Carine Roy,Isabelle Gorenne,Estelle Marcault,Pauline Manchon,Blandine Pasquet,Chandra Roy +254 more
TL;DR: Neuro-functional disability is frequently reported 12 months after community-acquired bacterial meningitis in adult patients and detailed neurological examination at discharge is needed to improve the follow-up.
1
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
Alexandre Duvignaud,Julie Chastang,Christine Binquet,Julie Dupouy,Alain Makinson,Roland Landman,Cédrick Wallet,Sophie Karcher,Valérie Journot,Duc Nguyen,Stéphane Bouchet,Marie-Edith Lafon,Mathieu Molimard,Laura Richert,Olivier Saint-Lary,Sarah Djabarouti,Denis Malvy,G. Duluc,Daniela Arma,P. Beaufrere,J. Belcastro,Thomas Brice,Paolo Cassai,Sacha Desjardins,Jessica Durrieu,S. Georgevail,Anne Gimbert,Sébastien Marchi,Valérie Marty,Fabienne Nacka,R. Pinilla,Pierre Poulizac,Sophie C. Regueme,Marine Rousset,Caroline Roussillon,F. Salvo,J.M. Soria,Sandrine Vautrat,Florence Allais,Silvia Canete,Nathalie Chaghil,Samira Daoui,Gaelle Dupouy,Laure Esterle,Valerie Favreau,Ambre Gelley,Stéphanie Gillet,Lucile Hardel,Myriam Kanté,Edouard Lhomme,Soledad Martiren,Laetitia Moinot,Loretxu Pinoges,Erica Fornaris Rouch,Christine Schwimmer,Rémi Sitta,Monique Termote,Linda Wittkop,Xavier Anglaret,Eric Balestre,C. Beuscart,Christine Bonnier,Cécile Cazes,Corine Chazallon,G. Clouet,Maguy Daures,Delphine Gabillard,G. Habiyambere,Michal Loniewski,J. Le Carrou,O. Marcy,Valérie Murat,J. Orne Gliemann,Melanie Plazy,Bellabes Ghezzoul,L. Delignac,Pauline Etienne,Virginie Fulda,M. Gigan,Claire Langlade,J. Le Chanjour,P. Marque,Pedro Mora,C Plessis,B. Sourisseau,Isabelle Pellegrin,C. Cognet,Isabelle Garrigue,Julien Jeanpetit,Agnès Pouzet,Arthur Tarricone,Pascale Trimoulet,Aline Voldoire,Christine Lacabaratz,Hamid Hocini,C. Bez,Evelyne Bironneau,Elodie Collomb,A. Contamin,C. Dubourdieu,N. Faure,Martin F. Galinski,P. Gibaud,Cédric Gil-Jardiné,J. Guillot-Warin,C. Lebouc,A. Leger,V. Lengline,Claire Loizeau,M. Mayenc,Nastasja Merle,H. Nadiri-Kahraman,D. Nguyen,M Odorico,R. Onaisi,Thierry Pistone,F. Sacher,Jean-Louis Scandella,F. Velardo,A. Wiet,T. Boudon,O. Bouissière,R. Brégéras,N. Broennec,Claire Gazille,Cynthia Grenier,Gérard-Menan Kouamé,C. Martins-Calado,Jean-Baptiste Ntakpe,Z. Pascual,Lionel Piroth,S. Court Devilliers,Joy W. Darley,F. Ducherpozat,N. Eberard,J. L. Faure,Henri Portier,R. Rochelet,C Ruffino,R. Thevenoud,T. T. Creusvaux-Nguyen,Norbert Desbiolles,Alexandre Grattard,A. Lamotte Felin,L. Rossye,Cynthia Schaeffer,Fernanda Silvestre,C. E. Simonel,Benjamin Lefevre,G. Baronnet,E. Baux,C. Di Santolo,M. Ferry,François Goehringer,Claire Daguin,Estelle P. Dauchy,Morgane Gilg,Patrick Rossignol,A. Boucault,Laetitia Gimenez,C. Burguier,Mathilde Couderc,C. Fradet,Anais Gervais,Julien Lavergne,Chris Landon,S. Mathe,B. Ortala,Nadera Ainaoui,S. Auriac,S.Bras,S. Flasquin,C. Frayssé,Munir Gabriel,Pascale Gauteul,J. Germain,Florian Gross,Claire Lebely,Christelle Riviere,D. Robert,Claire Thalamas,T. Darnaud,D. Poitrenaud,Irene Giusti,S. Provent,Ana Montoya-Ferrer,Jjj Battery,Nathalie Coux,L. Crantelle,Florence Galtier,Calire Martin,Marie-Christine Picot,Josselin Le Bel,Anh V. Nguyen,Isabelle Giraud,Jean-Marc Naccache,J. Jouveshomme,Edouard Devaud,Nesrine Ben Nasr,Rita Tchematcha Monkam,E. Sacco,Sandrine Rullé,Karine Amat,Aida Benalicherif,Babacar Sylla,C. Begue,Cédric Rat,Clement L. Bouve,C. Huard,Stephane Morgand,Eric Guegan,Damien Fairier,Annie Loiez,T. Alcouffe,Valérie Briand,S. Coudray,Daniel Charles,Hélène Jacquet,Claire Levy-Marchal,John Messo Raude,Philippe Vellozzo,P. Whithenay,Xavier de Lamballerie,Laëtitia Atlani-Duault,Franck Chauvin,David Darmon,Pierre-Louis Druais,Vincent Dubée,David Lebeaux,D Malvy,F. Mentré,J. Michel,Jean-Louis Montastruc,Olivier Saint Lary,Rodolphe Thiébaut,Lilia Weiss,Carlos Poblete Cazenave,Saray Conde,A Cremer,C. Gil Jardine,Jean-Philippe Joseph,Louis Letinier,Jennifer D. Nguyen,Thierry Schaeverbeke,Dominique Costagliola,Eric Bellissant,Gaëtan Gavazzi,C. Locher,Anne-Marie Taburet,Pierre Tattevin,S. Walker +250 more
TL;DR: In this paper , the authors evaluated the efficacy of inhaled ciclesonide in reducing the risk of adverse outcomes in COVID-19 outpatients at risk of developing severe illness.
Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial.
Vincent Dubée,Pierre-Marie Roy,Bruno Vielle,Elsa Parot-Schinkel,Odile Blanchet,Astrid Darsonval,Caroline Lefeuvre,Chadi Abbara,Sophie Boucher,Edouard Devaud,Olivier Robineau,Patrick Rispal,Thomas Guimard,Emma d’Anglejean,Sylvain Diamantis,Marc-Antoine Custaud,Isabelle Pellier,Alain Mercat +17 more
TL;DR: A randomized double-blind placebo-controlled trial evaluating hydroxychloroquine in COVID-19 patients with at least one of the following risk factors for worsening: need for supplemental oxygen, age ≥75 years, age between 60 and 74 years, and presence of a co-morbidity.